Ranbaxy Q1 cons net up 19.91% Rs 153 cr

Published on Tue, Apr 22, 2008 at 13:33 |  Source : CNBC-TV18

Updated at Tue, Apr 22, 2008 at 14:29  

54204 Investors following Ranbaxy Labs. Share this News with them.
0
0
Share on Tumblr

Ranbaxy Labs has announced its first quarter results. It has posted consolidated net profit of Rs 153 crore as against Rs 127.6 in the same quarter of last year, growth of 19.91%. Net sales went up by 3.78% at Rs 1623.1 crore from Rs 1564 crore.

It has reported net sales of USD 409 million versus USD 355 million and net profit of USD 39 million versus USD 32 million. Forex gains stood at Rs 79.8 crore versus loss of Rs 55.9 croer (YoY).

According to CNBC-TV18 estimates, the company was expected to post net profit of Rs 139 crore on net sales of Rs 1731 crore.

Particulars Mar-08 Dec-07 Sep-07 Jun-07
Net Sales / Interest Earned / Operating Income 987.286 993.32 1038.12 1014.63
Other Income 87.68 124.79 115.32 73.37
Total Income 1074.966 1118.11 1153.44 1088
Expenditure -885.169 -1006.81 -883.37 -674.49
Operating Profit 189.797 111.3 270.07 413.51
Interest -26.246 -24.76 -26.27 -24.79
Profit Before Depreciation and Tax 163.551 86.54 243.8 388.72
Depreciation -32.149 -30.03 -32.52 -27.71
Profit before Tax 131.402 56.51 211.28 361.01
Tax -27.98 -8.11 -43.12 -69.86
Profit after Tax 103.422 48.4 168.16 291.15
Extraordinary Items - - - -
Net Profit 103.422 48.4 168.16 291.15
Equity Capital 186.535 186.54 186.48 186.43

  

More on Moneycontrol

Trending News

Business News

Logitech ZAAG iPad2 Keyboard Case
Competition ahoy: Monkey 1, Sensex in neck-and-neck race "Competition ahoy: Monkey 1, Sensex in neck-and-neck race"

From DJ Greek Fin Min Says Feb 17 Final Day For Greek Bond Exchange Offer

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 12 2012, 11:20

See more rally even if Greek crisis drags on: RBS

- in FII View

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 11 2012, 11:52 | Source: CNBC-TV18

TCS to expand centers in N.America; CY12 focus on Japan  

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com